Uterine Cancer (Endometrium Cancer)
Safe surgical solutions for your health with accurate diagnosis, safe intervention! NY Health is always ready with its professional team.
- Liver Cancer
- Lymphoma Cancer
- Leukemia
- Bladder Cancer
- Stomach Cancer
- Myelofibrosis
- Multiple Myeloma
- Nasopharyngeal Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Penis Cancer
- Prostate Cancer
- Uterine Cancer
- Testicular Cancer
- Thymoma Tumor
- Thyroid Cancer
- Urethna Cancer
- Mouth Cancer
- Lung Cancer
- Bowel (Colon) Cancer
- Kidney Cancer
- Skin Cancer
- Tongue Cancer
- Early Stage Breast Cancer
- Larynx Cancer
More information
Feel free to contact us for more information or support with your questions. We will be happy to help you.
Get in touch!Customer Service
+90 532 100 66 78
NY Health
UTERINE CANCER
Uterine Cancer (Endometrium Cancer)
The most common gynecological cancer type in women with a high success rate with early diagnosis
Uterine cancer is a malignant tumor that develops in the endometrium lining the lining of the uterus. It is caused by the uncontrolled proliferation of cells. The most common form is endometrioid adenocarcinoma. It usually manifests itself with postmenopausal bleeding and early detection is completely curable.
Symptoms of Uterine Cancer
Vaginal bleeding after menopause (most common symptom)
Menstrual irregularities (in women of reproductive age)
Bleeding or spotting after sexual intercourse
Watery, foul-smelling vaginal discharge
Pelvic (lower abdominal) pain or feeling of pressure
Unexplained weight loss
Burning during urination or frequent urination (advanced stage)
Every postmenopausal bleeding should be investigated for uterine cancer.
Risk Factors
- Postmenopausal age (especially over 50)
-Long-term exposure to the hormone estrogen (not giving birth, early menstruation / late menopause)
- Obesity and insulin resistance
- Polycystic ovary syndrome (PCOS)
- Family history of uterine, ovarian or colon cancer
- Long-term use of estrogen without supplemental progesterone
- Lynch syndrome (genetic predisposition)
Diagnosis Process
- Transvaginal ultrasonography (TVUS): Endometrium thickness is assessed
- Endometrial biopsy: A pathologic diagnosis is made by taking a tissue sample from inside the uterus
- Hysteroscopy: Examination of the uterus with a camera and sampling of the suspicious area
-CT/MR imaging: For tumor invasion and staging
- Tumor markers such as CA-125: May be supportive during follow-up
Staging
- Stage I: Cancer is confined to the uterus (most common and best prognosis)
- Stage II: Spread to the cervix
- Stage III: Spread to surrounding tissues or lymph nodes
- Stage IV: Metastasis to bladder, bowel or distant organs
Treatment Methods
Surgical Treatment (Gold standard)
-Total abdominal hysterectomy + bilateral salpingoopherectomy (removal of the uterus, both tubes and ovaries)
- Lymph node dissection if necessary (for invasion evaluation)
Radiotherapy
- Supportive therapy after surgery
- May be the main treatment modality in patients not suitable for surgery
- External irradiation (EBRT) or vaginal brachytherapy
Chemotherapy
- Systemic therapy for advanced or aggressive tumor types
Hormone Therapy
- Especially in early-stage, fertility-preserving patients or in low-grade tumors
is used
Process Management Suitable for Health Tourism Process Management Suitable for Health Tourism
- - Remote pre-assessment with ultrasound, biopsy and your reports
- - Preoperative preparations and council planning are carried out if necessary
- - Surgical and supportive treatment processes are coordinated with oncologic gynecologists
- - Accommodation, transfer, escort support is organized
- - Remote follow-up and counseling system is activated after treatment
Uterine cancer is a disease that can be treated with a success rate close to 90% with early diagnosis.
If you have complaints of non-menstrual bleeding, especially after menopause, you can get an evaluation immediately.